Literature DB >> 30530600

Successful Treatment of Bacteremia Due to NDM-1-Producing Morganella morganii with Aztreonam and Ceftazidime-Avibactam Combination in a Pediatric Patient with Hematologic Malignancy.

Claire Amaris Hobson1, Stéphane Bonacorsi1,2, Mony Fahd3, André Baruchel3, Aurélie Cointe1,2, Nora Poey4, Hervé Jacquier1,5, Catherine Doit1,2, Audrey Monjault2, Olivier Tenaillon1, André Birgy6,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30530600      PMCID： PMC6355611          DOI： 10.1128/AAC.02463-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  10 in total

1.  SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing.

Authors:  Anton Bankevich; Sergey Nurk; Dmitry Antipov; Alexey A Gurevich; Mikhail Dvorkin; Alexander S Kulikov; Valery M Lesin; Sergey I Nikolenko; Son Pham; Andrey D Prjibelski; Alexey V Pyshkin; Alexander V Sirotkin; Nikolay Vyahhi; Glenn Tesler; Max A Alekseyev; Pavel A Pevzner
Journal:  J Comput Biol       Date:  2012-04-16       Impact factor: 1.479

2.  Pharmacokinetics/pharmacodynamics of a β-lactam and β-lactamase inhibitor combination: a novel approach for aztreonam/avibactam.

Authors:  Renu Singh; Aryun Kim; M Angela Tanudra; Jennifer J Harris; Robert E McLaughlin; Sara Patey; John P O'Donnell; Patricia A Bradford; Ann E Eakin
Journal:  J Antimicrob Chemother       Date:  2015-05-29       Impact factor: 5.790

3.  Ceftazidime-Avibactam and Aztreonam, an Interesting Strategy To Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae and Pseudomonas aeruginosa.

Authors:  Benjamin Davido; Lesly Fellous; Christine Lawrence; Virginie Maxime; Martin Rottman; Aurélien Dinh
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

4.  In vitro activity of ceftazidime, ceftaroline and aztreonam alone and in combination with avibactam against European Gram-negative and Gram-positive clinical isolates.

Authors:  Raymond Testa; Rafael Cantón; Tommaso Giani; María-Isabel Morosini; Wright W Nichols; Harald Seifert; Danuta Stefanik; Gian Maria Rossolini; Patrice Nordmann
Journal:  Int J Antimicrob Agents       Date:  2015-02-17       Impact factor: 5.283

5.  Ceftazidime/avibactam alone or in combination with aztreonam against colistin-resistant and carbapenemase-producing Klebsiella pneumoniae.

Authors:  Aurélie Jayol; Patrice Nordmann; Laurent Poirel; Véronique Dubois
Journal:  J Antimicrob Chemother       Date:  2018-02-01       Impact factor: 5.790

6.  Clinical outcomes after combination treatment with ceftazidime/avibactam and aztreonam for NDM-1/OXA-48/CTX-M-15-producing Klebsiella pneumoniae infection.

Authors:  Evelyn Shaw; Alexander Rombauts; Fe Tubau; Ariadna Padullés; Jordi Càmara; Toni Lozano; Sara Cobo-Sacristán; Núria Sabe; Imma Grau; Raül Rigo-Bonnin; M Angeles Dominguez; Jordi Carratalà
Journal:  J Antimicrob Chemother       Date:  2018-04-01       Impact factor: 5.790

7.  Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?

Authors:  Steven Marshall; Andrea M Hujer; Laura J Rojas; Krisztina M Papp-Wallace; Romney M Humphries; Brad Spellberg; Kristine M Hujer; Emma K Marshall; Susan D Rudin; Federico Perez; Brigid M Wilson; Ronald B Wasserman; Linda Chikowski; David L Paterson; Alejandro J Vila; David van Duin; Barry N Kreiswirth; Henry F Chambers; Vance G Fowler; Michael R Jacobs; Mark E Pulse; William J Weiss; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

8.  Clinical efficacy of ceftazidime/avibactam versus other active agents for the treatment of bacteremia due to carbapenemase-producing Enterobacteriaceae in hematologic patients.

Authors:  Juan J Castón; Isabel Lacort-Peralta; Pilar Martín-Dávila; Belén Loeches; Salvador Tabares; Liz Temkin; Julián Torre-Cisneros; José R Paño-Pardo
Journal:  Int J Infect Dis       Date:  2017-04-06       Impact factor: 3.623

9.  Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae.

Authors:  Mario Tumbarello; Enrico Maria Trecarichi; Alberto Corona; Francesco Giuseppe De Rosa; Matteo Bassetti; Cristina Mussini; Francesco Menichetti; Claudio Viscoli; Caterina Campoli; Mario Venditti; Andrea De Gasperi; Alessandra Mularoni; Carlo Tascini; Giustino Parruti; Carlo Pallotto; Simona Sica; Ercole Concia; Rosario Cultrera; Gennaro De Pascale; Alessandro Capone; Spinello Antinori; Silvia Corcione; Elda Righi; Angela Raffaella Losito; Margherita Digaetano; Francesco Amadori; Daniele Roberto Giacobbe; Giancarlo Ceccarelli; Ernestina Mazza; Francesca Raffaelli; Teresa Spanu; Roberto Cauda; Pierluigi Viale
Journal:  Clin Infect Dis       Date:  2019-01-18       Impact factor: 9.079

10.  Identification of acquired antimicrobial resistance genes.

Authors:  Ea Zankari; Henrik Hasman; Salvatore Cosentino; Martin Vestergaard; Simon Rasmussen; Ole Lund; Frank M Aarestrup; Mette Voldby Larsen
Journal:  J Antimicrob Chemother       Date:  2012-07-10       Impact factor: 5.790
  10 in total
  12 in total

Review 1.  Carbapenem-Resistant Gram-Negative Bacterial Infections in Children.

Authors:  David Aguilera-Alonso; Luis Escosa-García; Jesús Saavedra-Lozano; Emilia Cercenado; Fernando Baquero-Artigao
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

2.  Aztreonam Combination Therapy: An Answer to Metallo-β-Lactamase-Producing Gram-Negative Bacteria?

Authors:  Ryan K Shields; Yohei Doi
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079

3.  Intravenous Ceftazidime-Avibactam in Extremely Premature Neonates With Carbapenem-Resistant Enterobacteriaceae: Two Case Reports.

Authors:  Suzan S Asfour; Faisal A Alaklobi; Adli Abdelrahim; Muhammed Y Taha; Raneem S Asfour; Thanaa M Khalil; Mountasser M Al-Mouqdad
Journal:  J Pediatr Pharmacol Ther       Date:  2022-02-09

4.  Successful treatment of Verona integron-encoded metallo-β-lactamase-producing Klebsiella pneumoniae infection using the combination of ceftazidime/avibactam and aztreonam.

Authors:  Ana Pelaez Bejarano; Raquel Sánchez-Del Moral; Olalla Montero-Pérez; Francisco Javier Martínez-Marcos
Journal:  Eur J Hosp Pharm       Date:  2021-10-29

5.  The Rapid Emergence of Ceftazidime-Avibactam Resistance Mediated by KPC Variants in Carbapenem-Resistant Klebsiella pneumoniae in Zhejiang Province, China.

Authors:  Congcong Liu; Yuchen Wu; Ling Huang; Yanyan Zhang; Qiaoling Sun; Jiayue Lu; Yu Zeng; Ning Dong; Chang Cai; Zhangqi Shen; Gongxiang Chen; Rong Zhang
Journal:  Antibiotics (Basel)       Date:  2022-05-30

Review 6.  Optimal Management of Complicated Infections in the Pediatric Patient: The Role and Utility of Ceftazidime/Avibactam.

Authors:  Matteo Bassetti; Maddalena Peghin; Alessio Mesini; Elio Castagnola
Journal:  Infect Drug Resist       Date:  2020-06-12       Impact factor: 4.003

7.  CP-CRE/non-CP-CRE Stratification And CRE Resistance Mechanism Determination Help In Better Managing CRE Bacteremia Using Ceftazidime-Avibactam And Aztreonam-Avibactam.

Authors:  Hua Zou; Sen-Jie Xiong; Qiu-Xia Lin; Meng-Lu Wu; Si-Qiang Niu; Shi-Feng Huang
Journal:  Infect Drug Resist       Date:  2019-09-23       Impact factor: 4.003

Review 8.  Ceftazidime/Avibactam and Ceftolozane/Tazobactam for Multidrug-Resistant Gram Negatives in Patients with Hematological Malignancies: Current Experiences.

Authors:  Marianna Criscuolo; Enrico Maria Trecarichi
Journal:  Antibiotics (Basel)       Date:  2020-02-03

Review 9.  Therapeutic Options for Metallo-β-Lactamase-Producing Enterobacterales.

Authors:  Xing Tan; Hwan Seung Kim; Kimberly Baugh; Yanqin Huang; Neeraja Kadiyala; Marisol Wences; Nidhi Singh; Eric Wenzler; Zackery P Bulman
Journal:  Infect Drug Resist       Date:  2021-01-18       Impact factor: 4.003

10.  Successful rescue treatment of sepsis due to a pandrug-resistant, NDM-producing Klebsiella pneumoniae using aztreonam powder for nebulizer solution as intravenous therapy in combination with ceftazidime/avibactam.

Authors:  Elske Sieswerda; Marre van den Brand; Roland B van den Berg; Joris Sträter; Leo Schouls; Karin van Dijk; Andries E Budding
Journal:  J Antimicrob Chemother       Date:  2020-03-01       Impact factor: 5.790
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.